9.2 C
London
Friday, October 18, 2024
Subscribe
HomeTagsEisai's

Tag: Eisai's

spot_imgspot_img
Business

Japan – Eisai’s Antiepileptic Drug Fycompa Approved in China for Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures

Eisai Co., Ltd. announced today that it has received approval in China for the additional indication of its in-house discovered antiepileptic drug (AED) Fycompa®...
Business

Japan – Eisai’s Antiepileptic Drug Fycompa Injection Formulation Launched In Japan

Eisai Co., Ltd. announced today that the injection formulation of its in-house discovered antiepileptic drug (AED) Fycompa (perampanel hydrate) for intravenous (IV) infusion has...
Business

Japan – Eisai’s Sales Subsidiary Collaborates with Ministry of Public Health (MOPH) in Thailand

Eisai Co., Ltd. announced today that its Thai sales subsidiary Eisai (Thailand) Marketing Co., Ltd., (Eisai Thailand) has made an agreement to collaborate with...
Business

Japan – Eisai’s Initiatives for Developing New Medicines for Neglected Tropical Diseases and Malaria and Commitment for Funding to the 3rd Phase of Global...

Eisai Co., Ltd. has announced that it will grant a total of 625 million yen to the Global Health Innovative Technology Fund ("GHIT...
Business

Japan – FDA Accepts Eisai’s Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the...

Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that the U.S. Food and Drug Administration (FDA) has accepted Eisai's supplemental Biologics...
Business

Japan – Eisai’s Sales Subsidiary Collaborates with Thai Life Insurance to Support Access to Treatments for Dementia, Including Alzheimer’s Disease, in Thailand

Eisai Co., Ltd. announced today that its Thai sales subsidiary Eisai (Thailand) Marketing Co. Ltd. ("Eisai Thailand") made an agreement to collaborate in...
Business

Japan – Eisai’s Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint

Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced positive topline results from Eisai's large global Phase 3 confirmatory Clarity AD clinical trial...
12Page 1 of 2

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img

Company

Each template in our ever growing studio library can be added and moved around within any page effortlessly with one click.

Latest

HireScore Wins the Summer 2024 Top Performer Award in Applicant Tracking/Recruiting Software from SourceForge

Business 0
HireScore, the modern hiring platform for high-performance companies, today...

Leaders Art Advertising Expands Innovative Signage Solutions

Business 0
Leaders Art Advertising leverages cutting-edge technology and a talented...

The Knowledge Group Has Scheduled a Webcast on Unlocking the Power of Diversity: Elevating Equity, Inclusion, and Success in the Legal Profession

Business 0
Event Summary: In today's rapidly evolving legal landscape, diversity, equity,...

Popular

HireScore Wins the Summer 2024 Top Performer Award in Applicant Tracking/Recruiting Software from SourceForge

Business 0
HireScore, the modern hiring platform for high-performance companies, today...

Leaders Art Advertising Expands Innovative Signage Solutions

Business 0
Leaders Art Advertising leverages cutting-edge technology and a talented...

The Knowledge Group Has Scheduled a Webcast on Unlocking the Power of Diversity: Elevating Equity, Inclusion, and Success in the Legal Profession

Business 0
Event Summary: In today's rapidly evolving legal landscape, diversity, equity,...

Sitemap

© 2004-2024 Webnewswire, All Rights Reserved